Equity-Based Compensation (Schedule Of Stock Appreciation Rights Activity) (Details) - Stock Appreciation Rights (SARs) $ / shares in Units, $ in Thousands	12 Months Ended
	Oct. 02, 2021 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
SARs, Outstanding, Beginning of period | shares	984,270
SARs, Granted | shares	90,304
SARs, Exercised | shares	(172,642)
SARs, Expired | shares	(11,039)
SARs, Forfeited | shares	(7,470)
SARs, Outstanding, End of period | shares	883,423
SARs, Exercisable | shares	674,283
SARs, Weighted Average Exercise Price, Beginning of period | $ / shares	$ 67.07
SARs, Weighted Average Exercise Price, Granted | $ / shares	73.39
SARs, Weighted Average Exercise Price, Exercised | $ / shares	57.51
SARs, Weighted Average Exercise Price, Expired | $ / shares	74.39
SARs, Weighted Average Exercise Price, Forfeited | $ / shares	81.43
SARs, Weighted Average Exercise Price, End of period | $ / shares	69.37
SARs, Weighted Average Exercise Price, Exercisable | $ / shares	$ 66.20
SARs, Weighted Average Remaining Contractual Terms, Outstanding	5 years
SARs, Weighted Average Remaining Contractual Terms, Exercisable	4 years
SARs, Aggregate Intrinsic Value, Outstanding | $	$ 9,261
SARs, Aggregate Intrinsic Value, Exercisable | $	$ 8,922